MMS2 Antibody

What is MMS2 and what role does it play in cellular processes?

MMS2 (also known as UBE2V2, UEV2) is a ubiquitin-conjugating enzyme variant that lacks intrinsic ubiquitin ligase activity but forms a functional heterodimer with UBC13. This complex catalyzes the synthesis of non-canonical Lysine 63-linked polyubiquitin chains, distinct from the typical Lysine 48-linked chains that target proteins for proteasomal degradation . MMS2 plays a crucial role in DNA damage response by participating in polyubiquitin chain assembly, which is essential for signaling pathways that regulate DNA repair mechanisms .

In cellular processes, MMS2 functions include error-free DNA repair pathways, cell cycle control and progression, cellular differentiation, and transcriptional activation of target genes. The protein also contributes to the maintenance of genomic stability by preventing mutation accumulation that could otherwise lead to cancer development . The MMS2-UBC13 heterodimer specifically facilitates Lysine 63-linked polyubiquitin chain formation, which is vital for repair protein recruitment to DNA damage sites .

Beyond DNA repair, MMS2 interacts with other proteins involved in the ubiquitin-proteasome system, underscoring its significance in cellular processes including protein degradation regulation and signaling pathway modulation . Its role in maintaining genomic stability makes it a potential tumor suppressor, as defects in MMS2 function can increase susceptibility to cancer due to accumulated DNA damage .

What types of MMS2 antibodies are available for research?

Several types of MMS2 antibodies are available for research applications, varying in host species, clonality, and epitope recognition:

• Mouse Monoclonal Antibodies:

  • Example: Mms2 Antibody (2H11), a mouse monoclonal IgG1 antibody that detects Mms2 protein from mouse, rat, and human origins .

  • Applications: Western blotting (WB), immunofluorescence (IF), and enzyme-linked immunosorbent assay (ELISA) .

  • Advantages: High specificity and consistent lot-to-lot reproducibility.

• Rabbit Polyclonal Antibodies:

  • Example: Anti-MMS2 antibody (ab155007), a rabbit polyclonal antibody suitable for immunohistochemistry on paraffin-embedded tissues (IHC-P) and western blotting (WB) .

  • Applications: Detects mouse and human samples .

  • Immunogen: Recombinant Fragment Protein within Human UBE2V2 aa 1 to C-terminus .

When selecting an MMS2 antibody, researchers should consider target species compatibility (human, mouse, rat), intended applications (WB, IF, IHC, ELISA), required sensitivity and specificity, and available validation data. The choice between monoclonal and polyclonal antibodies should be based on the specific experimental needs, with monoclonals offering higher specificity and polyclonals potentially providing better sensitivity through recognition of multiple epitopes .

What detection methods can be used with MMS2 antibodies?

MMS2 antibodies can be utilized with several detection methods, each with specific advantages and protocols:

• Western Blotting (WB):

  • Provides information about protein molecular weight (approximately 15-17 kDa for MMS2) and relative abundance .

  • Both monoclonal and polyclonal MMS2 antibodies are validated for this application .

  • Essential for quantitative analysis of MMS2 protein levels across different experimental conditions.

  • Critical controls include positive control lysates and loading controls.

• Immunofluorescence (IF):

  • Reveals subcellular localization of MMS2 and can demonstrate colocalization with interaction partners (e.g., UBC13) .

  • Particularly useful for visualizing redistribution of MMS2 following DNA damage.

  • The mouse monoclonal Mms2 Antibody (2H11) is validated for this application .

• Immunohistochemistry on Paraffin-embedded tissues (IHC-P):

  • Useful for tissue-specific expression and localization studies .

  • The rabbit polyclonal anti-MMS2 antibody (ab155007) is validated for this application .

  • Provides context of MMS2 expression in relation to tissue architecture.

• Enzyme-linked Immunosorbent Assay (ELISA):

  • Allows quantitative detection of MMS2 in solution .

  • The mouse monoclonal Mms2 Antibody (2H11) is validated for this application .

  • Useful for high-throughput screening approaches.

For optimal results, researchers should optimize antibody concentrations through titration experiments, employ appropriate blocking reagents to reduce background, and include proper controls to validate specificity. The detection method choice should align with the research question - WB for protein level quantification, IF for localization studies, IHC-P for tissue expression patterns, and ELISA for quantitative analysis in solution .

What is the relationship between MMS2 and UBC13?

MMS2 (UBE2V2) and UBC13 (UBE2N) form a functional heterodimer that is essential for the synthesis of Lysine 63-linked polyubiquitin chains. This relationship is fundamental to understanding MMS2's biological functions:

• Functional Complementation:

  • MMS2 lacks intrinsic ubiquitin ligase activity but contributes to substrate specificity .

  • UBC13 provides the catalytic activity for ubiquitin conjugation .

  • Together, they specifically catalyze K63-linked (not K48-linked) polyubiquitination .

• Biochemical Activity:

  • The UBE2V2/UBE2N (MMS2/UBC13) heterodimer catalyzes the synthesis of non-canonical poly-ubiquitin chains linked through 'Lys-63' .

  • This type of poly-ubiquitination does not lead to protein degradation by the proteasome, distinguishing it from conventional K48-linked chains .

• Cellular Functions:

  • The MMS2-UBC13 complex is recruited to sites of DNA damage .

  • It facilitates the recruitment of repair proteins through K63-linked ubiquitination .

  • This complex plays a role in the error-free DNA repair pathway and contributes to cell survival after DNA damage .

  • Additionally, it mediates transcriptional activation of target genes and plays a role in cell cycle control and differentiation .

When designing experiments to study MMS2, consideration of its UBC13 partner is essential, as many functions attributed to MMS2 are dependent on this heterodimeric relationship. The interaction forms a biologically significant unit that maintains genomic stability and prevents mutation accumulation that could lead to cancer .

How does MMS2 contribute to DNA repair mechanisms?

MMS2 plays a vital role in DNA repair mechanisms, particularly in the error-free DNA damage tolerance pathway, through several key mechanisms:

• K63-linked Polyubiquitination:

  • MMS2, in complex with UBC13, catalyzes K63-linked polyubiquitination at sites of DNA damage .

  • This modification is distinct from K48-linked chains that signal for protein degradation .

  • K63-linked ubiquitination serves as a molecular signal to recruit repair factors .

• Error-Free DNA Repair:

  • MMS2 plays a crucial role in the error-free DNA repair pathway .

  • This pathway allows for accurate repair of DNA damage without introducing mutations.

  • Contributes significantly to cell survival after DNA damage .

• Genomic Stability Maintenance:

  • By facilitating accurate repair, MMS2 prevents mutation accumulation .

  • Its function helps maintain genomic stability and prevents mutation accumulation that could lead to cancer .

  • Defects in MMS2 function can lead to increased susceptibility to cancer through genomic instability .

• Repair Complex Assembly:

  • MMS2-mediated ubiquitin chains create a scaffold for assembly of repair proteins .

  • Facilitates the recruitment of specialized DNA repair proteins to damage sites .

  • This function is essential for signaling pathways that regulate DNA repair mechanisms .

The significance of MMS2 in DNA repair extends beyond its direct enzymatic function. Its role in the ubiquitin-proteasome system underscores its importance in cellular processes including protein degradation regulation and signaling pathway modulation. Using anti-MMS2 antibodies in research can provide valuable insights into DNA repair mechanisms and the broader implications of ubiquitin signaling in cellular health and disease .

How can researchers optimize western blotting protocols for MMS2 detection?

Optimizing western blotting for MMS2 detection requires careful consideration of several technical aspects due to its relatively small size (approximately 15-17 kDa) and specific biochemical properties:

• Sample Preparation:

  • Complete lysis buffers containing protease inhibitors are essential to prevent degradation.

  • For capturing DNA damage-dependent modifications, consider harvesting cells at various timepoints following DNA damage induction.

  • Nuclear extraction protocols may be necessary as MMS2 can shuttle between cytoplasm and nucleus.

  • Recommended lysis buffer: RIPA buffer supplemented with 1% protease inhibitor cocktail.

• Gel Electrophoresis Parameters:

  • Use 12-15% polyacrylamide gels for optimal resolution of the low molecular weight MMS2 protein.

  • Consider gradient gels (4-20%) when analyzing MMS2 interactions with larger proteins.

  • Load 20-40 μg of total protein per lane for standard cell lines to ensure adequate signal.

• Transfer Conditions:

  • Semi-dry transfer: 15V for 30-45 minutes works efficiently for small proteins.

  • Wet transfer: 100V for 60 minutes or 30V overnight at 4°C.

  • PVDF membranes (0.2 μm pore size) are preferable for small proteins like MMS2.

  • Consider adding 10-20% methanol to the transfer buffer to improve retention of small proteins.

• Antibody Selection and Dilution:

  • For mouse monoclonal Mms2 Antibody (2H11): Recommended concentration of 200 μg/ml .

  • For rabbit polyclonal anti-MMS2 (ab155007): Optimize dilutions through titration experiments.

  • Overnight incubation at 4°C often yields cleaner results than short incubations.

  • HRP-conjugated secondary antibodies at 1:5000 to 1:10000 dilution.

• Critical Controls:

  • Positive control: Lysate from cells known to express MMS2 (e.g., HEK293, HeLa).

  • Negative control: Lysate from MMS2-knockdown cells or tissues.

  • Loading control: β-actin, GAPDH, or other housekeeping proteins.

  • Multiple controls are essential as MMS2 forms a heterodimer with UBC13 and participates in complex cellular processes .

When troubleshooting, common issues include high background (addressable by increasing blocking time or changing blocking reagent) and weak signal (which may require longer exposure times or higher antibody concentration). For detecting MMS2 in the context of DNA damage studies, consider comparing samples before and after treatment with DNA-damaging agents to observe potential changes in protein levels or mobility shifts due to post-translational modifications .

What are the considerations when using MMS2 antibodies in multiplexed immunofluorescence experiments?

Multiplexed immunofluorescence with MMS2 antibodies requires careful planning to achieve reliable and interpretable results, particularly when studying its interactions with partner proteins:

• Antibody Compatibility Assessment:

  • Host species considerations: When studying MMS2-UBC13 interaction, select antibodies from different host species (e.g., rabbit anti-MMS2 and mouse anti-UBC13).

  • When studying MMS2 in the context of DNA damage, consider co-staining with established DNA damage markers like γH2AX or 53BP1.

  • Isotype differences can be leveraged when antibodies are from the same species.

• Sample Preparation Optimization:

  • Fixation method affects epitope accessibility: 4% paraformaldehyde (10-15 minutes) works well for most applications.

  • Permeabilization is critical: 0.1-0.5% Triton X-100 (5-10 minutes) for nuclear proteins like MMS2.

  • Blocking conditions: 5% normal serum from the species of the secondary antibody reduces background.

  • Antigen retrieval may be necessary for some fixation methods.

• Experimental Design for MMS2 Studies:

  • MMS2 colocalizes with DNA repair factors after damage induction .

  • Design time-course experiments following DNA damage to capture dynamic responses.

  • Include untreated controls to establish baseline localization patterns.

  • Consider cell cycle synchronization as MMS2 function may vary across cell cycle phases.

• Controls for Multiplexed Experiments:

  • Single-stained controls for each antibody to establish proper exposure settings.

  • Secondary-only controls to assess background.

  • Blocking peptide controls to confirm specificity.

  • Biological controls (e.g., MMS2 knockdown cells).

• Image Acquisition Parameters:

  • Capture sequential images to minimize bleed-through.

  • Use consistent exposure settings across experimental conditions.

  • Z-stack imaging may be necessary for accurate co-localization assessment.

  • High magnification (60-100x) is often required to resolve nuclear foci formation.

When specifically studying MMS2's role in DNA repair, researchers should induce DNA damage using agents like UV radiation, ionizing radiation, or chemical agents (e.g., MMS, cisplatin), and then track MMS2 redistribution to damage sites. The formation of discrete nuclear foci containing MMS2 is often indicative of its recruitment to DNA damage sites, where it facilitates the formation of K63-linked polyubiquitin chains essential for repair factor recruitment .

How can researchers validate the specificity of MMS2 antibodies?

Validating antibody specificity is crucial for generating reliable research data. For MMS2 antibodies, a comprehensive validation approach includes multiple complementary techniques:

• Genetic Validation Approaches:

  • siRNA/shRNA knockdown: Compare staining patterns in control versus MMS2-depleted samples.

  • CRISPR/Cas9 knockout: Generate MMS2-null cells as definitive negative controls.

  • Overexpression systems: Transfect with tagged MMS2 constructs and confirm co-detection.

  • Rescue experiments: Reintroduce MMS2 in knockout cells to restore staining patterns.

• Biochemical Validation Methods:

  • Western blot analysis: Confirm single band at expected molecular weight (~15-17 kDa) .

  • Immunoprecipitation followed by mass spectrometry: Verify pulled-down proteins include known MMS2 interaction partners like UBC13 .

  • Peptide competition assays: Pre-incubate antibody with immunizing peptide to block specific binding.

• Cross-reactivity Assessment:

  • Test against related proteins (e.g., UEV1/UBE2V1, which has similar functions) .

  • Cross-species validation if working with multiple model organisms (antibodies may detect MMS2 from mouse, rat, and human origins) .

  • Testing in tissues known to have high or low MMS2 expression.

• Functional Validation Strategies:

  • Verify expected subcellular localization patterns.

  • Confirm redistribution following DNA damage stimuli, as MMS2 is recruited to damage sites .

  • Demonstrate co-localization with known interaction partners (e.g., UBC13) .

• Validation Data Documentation:

Special considerations for MMS2 antibodies include distinguishing between MMS2/UBE2V2 and the related UEV1/UBE2V1 protein, accounting for potential post-translational modifications that may affect epitope recognition, and validating antibody performance in the specific experimental context in which it will be used .

What is the significance of K63-linked polyubiquitination in MMS2-related studies?

K63-linked polyubiquitination, catalyzed by the MMS2-UBC13 complex, represents a distinct ubiquitin signal with unique biological significance compared to conventional K48-linked chains:

• Signaling Function vs. Degradation:

  • K63-linked chains: Primarily function as non-proteolytic signals for protein recruitment and complex assembly .

  • K48-linked chains: Direct proteins to the 26S proteasome for degradation.

  • This distinction is fundamental for interpreting MMS2 function in cellular processes .

• Molecular Function in DNA Repair:

  • MMS2, in complex with UBC13, facilitates Lysine 63-linked polyubiquitin chain formation .

  • These chains are vital for repair protein recruitment to DNA damage sites .

  • This signaling is distinct from degradative ubiquitination and promotes assembly of repair complexes .

  • Through this mechanism, MMS2 contributes to maintaining genomic stability and prevents mutation accumulation .

• Biological Processes Regulated by K63 Linkages:

• Experimental Approaches for Studying K63 Chains in MMS2 Research:

  • Linkage-specific ubiquitin antibodies to distinguish K63 from other chain types.

  • Mass spectrometry methods for identifying and quantifying specific ubiquitin linkages.

  • Reconstitution assays using purified components to study chain formation in vitro.

  • Mutational analysis of substrate lysine residues to identify modification sites.

• Physiological Implications of MMS2-mediated K63 Ubiquitination:

  • Genomic stability: Proper DNA repair through error-free pathways .

  • Cancer susceptibility: Defects in MMS2 function can lead to increased mutagenesis and cancer .

  • Cellular differentiation: MMS2 plays a role in differentiation processes .

Understanding the specific role of K63-linked polyubiquitination catalyzed by the MMS2-UBC13 complex provides crucial insights into how cells maintain genomic integrity and respond to DNA damage. This non-proteolytic ubiquitin signaling represents a distinct regulatory mechanism with broad implications for cellular homeostasis and disease prevention .

How does MMS2 function in the context of DNA damage response signaling pathways?

MMS2 operates within a complex network of DNA damage response (DDR) signaling pathways, interacting with multiple components to coordinate appropriate cellular responses:

• Integration in the DDR Signaling Cascade:

  • Initial damage recognition: DNA damage sensors detect lesions.

  • Signal transduction: Phosphorylation events initiate the signaling cascade.

  • Recruitment phase: MMS2-UBC13 complex is recruited to damage sites.

  • Amplification: K63-linked ubiquitination creates a scaffold for further protein assembly .

  • Effector activation: Repair proteins and checkpoint mediators are recruited .

• Specific Role in DNA Repair Pathways:

  • MMS2 plays a crucial role in the error-free DNA repair pathway .

  • It contributes to cell survival after DNA damage by facilitating proper repair mechanisms .

  • MMS2 forms a complex with UBC13, enabling K63-linked polyubiquitination at damage sites .

  • This specific ubiquitination is vital for repair protein recruitment to DNA damage sites .

• Signaling Network Interactions:

  • MMS2-UBC13 heterodimer catalyzes the synthesis of non-canonical poly-ubiquitin chains linked through 'Lys-63' .

  • These chains serve as recognition signals for the assembly of repair complexes rather than directing protein degradation .

  • MMS2's interaction with other proteins in the ubiquitin-proteasome system extends its influence to multiple cellular processes .

• Functional Outcomes of MMS2 Activity in DDR:

  • Maintenance of genomic stability through accurate DNA repair .

  • Prevention of mutation accumulation that could lead to cancer .

  • Regulation of cell cycle progression in response to DNA damage .

  • Contribution to cellular differentiation processes .

• Experimental Approaches to Study MMS2 in DDR:

  • Chromatin immunoprecipitation: Assess association with damaged DNA.

  • Proximity ligation assay: Detect interactions with other DDR proteins.

  • Immunofluorescence: Track redistribution to damage sites .

  • Functional assays: Measure DNA repair efficiency in MMS2-deficient versus proficient cells.

The critical importance of MMS2 in DNA damage response signaling pathways underscores its potential as a research target for understanding genomic stability maintenance and cancer prevention mechanisms. Using anti-MMS2 antibodies in these studies can provide valuable insights into DNA repair mechanisms and the broader implications of ubiquitin signaling in cellular health and disease .